Therapy Near Me Mental Health Articles

Selective Serotonin Reuptake Inhibitors (SSRIs) are widely prescribed antidepressants, mainly used to treat mood disorders such as depression, anxiety, obsessive-compulsive disorder (OCD), and post-traumatic stress disorder (PTSD). Since their introduction in the 1980s, SSRIs have been recognised for their relatively mild side effect profile compared to older antidepressants, such as tricyclic antidepressants (TCAs) and monoamine oxidase inhibitors (MAOIs). This article will explore the mechanisms, uses, effectiveness, side effects, and future of SSRIs.

SSRIs function by increasing the levels of serotonin, a neurotransmitter linked to mood regulation, by inhibiting its reabsorption (reuptake) into neurons. This mechanism ensures that more serotonin remains available in the brain’s synaptic cleft, which enhances communication between nerve cells. The increased serotonin levels help alleviate symptoms of mood disorders such as depression and anxiety (Jenkins et al., 2016).

1. Fluoxetine (Prozac): Known for its long half-life and use in treating depression, OCD, and panic disorders (Baldwin et al., 2014).
2. Sertraline (Zoloft): Widely prescribed for depression, PTSD, OCD, and social anxiety disorder (Cipriani et al., 2018).
3. Citalopram (Celexa): Primarily used for depression but also effective for anxiety (Ladea & Papakostas, 2019).
4. Escitalopram (Lexapro): A more refined form of citalopram, used for depression and generalised anxiety disorder (Llorca et al., 2014).
5. Paroxetine (Paxil): Effective for social anxiety and PTSD but associated with higher rates of side effects (Gartlehner et al., 2017).

SSRIs are primarily used to treat major depressive disorder (MDD), but they are also effective in treating:

• Generalised Anxiety Disorder (GAD): Reduces excessive worry and anxiety.
• Obsessive-Compulsive Disorder (OCD): Reduces compulsive behaviours and obsessive thoughts (Bloch et al., 2010).
• Panic Disorder: Alleviates panic attacks (Cipriani et al., 2018).
• Post-Traumatic Stress Disorder (PTSD): SSRIs like sertraline help in reducing PTSD symptoms (Benedek et al., 2009).
• Social Anxiety Disorder (SAD): Helps reduce fear and avoidance associated with SAD (Schneier et al., 2017).

SSRIs have been proven effective in treating depression and anxiety disorders. They are especially beneficial for patients with moderate to severe depression. In a meta-analysis, Cipriani et al. (2018) demonstrated that SSRIs significantly improve mood and reduce anxiety. However, responses can vary, and some patients may require adjustments to dosages or switching to different SSRIs for optimal results.

While SSRIs are generally well-tolerated, they can cause side effects, including:

• Nausea
• Insomnia or Drowsiness
• Sexual Dysfunction: A common side effect affecting libido and sexual performance (Serretti & Chiesa, 2009).
• Weight Gain: Associated with long-term use.
• Withdrawal Symptoms: Abrupt discontinuation can lead to dizziness, nausea, and headaches, known as SSRI discontinuation syndrome (Schatzberg et al., 2006).

• Pregnancy: While SSRIs are generally considered safe, there is a risk of birth defects, and their use during pregnancy should be evaluated on a case-by-case basis (Yonkers et al., 2009).
• Children and Adolescents: SSRIs are prescribed with caution in younger populations due to the increased risk of suicidal thoughts and behaviours (Bridge et al., 2007).

Ongoing research is exploring ways to enhance the effectiveness of SSRIs, including personalised medicine, which aims to tailor antidepressants based on genetic markers. This could help reduce the trial-and-error process that often accompanies antidepressant treatment (Amare et al., 2019). The development of serotonin-norepinephrine reuptake inhibitors (SNRIs) and other antidepressants also provides more options for patients who may not respond to SSRIs.

Selective Serotonin Reuptake Inhibitors (SSRIs) are a cornerstone in the treatment of depression and anxiety disorders. They have revolutionised mental health treatment by offering an effective and generally well-tolerated option for patients. However, like all medications, they are not without side effects, and ongoing research aims to improve their efficacy and reduce adverse reactions.

• Baldwin, D. S., Anderson, I. M., Nutt, D. J., et al. (2014). Evidence-based pharmacological treatment of anxiety disorders, PTSD, and OCD: Guidelines from the British Association for Psychopharmacology. Journal of Psychopharmacology, 28(5), 403-439.
• Bloch, M. H., McGuire, J., Landeros-Weisenberger, A., et al. (2010). Meta-analysis of SSRIs in obsessive-compulsive disorder. Molecular Psychiatry, 15(8), 850-855.
• Cipriani, A., Furukawa, T. A., Salanti, G., et al. (2018). Comparative efficacy of antidepressants for treating adults with major depressive disorder. The Lancet, 391(10128), 1357-1366.
• Gartlehner, G., Hansen, R. A., Morgan, L. C., et al. (2017). Comparative benefits and harms of SSRIs for social anxiety disorder. Psychopharmacology Review, 22(4), 403-412.
• Jenkins, T. A., Nguyen, J. C., Polglaze, K. E., & Bertrand, P. P. (2016). Influence of tryptophan and serotonin on mood and cognition with a possible role of the gut-brain axis. Nutrients, 8(1), 56.
• Serretti, A., & Chiesa, A. (2009). Treatment-emergent sexual dysfunction related to SSRIs. Journal of Clinical Psychopharmacology, 29(2), 259-266.
• Yonkers, K. A., Wisner, K. L., Stewart, D. E., et al. (2009). The management of depression during pregnancy: A report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. Obstetrics and Gynecology, 114(3), 703-713.

How to get in touch

If you or your NDIS participant need immediate mental healthcare assistance, feel free to get in contact with us on 1800 NEAR ME – admin@therapynearme.com.au.